Application
ST6GAL2 Antibody (C-term) western blot analysis in HepG2 cell line lysates (35ug/lane).This demonstrates the ST6GAL2 antibody detected the ST6GAL2 protein (arrow).| Product Name | ST6GAL2 (C-term) |
|---|---|
| Antibody Type | Primary Antibodies |
| Antigen Alias | ST6GAL2; KIAA1877; SIAT2; Beta-galactoside alpha-2, 6-sialyltransferase 2; CMP-N-acetylneuraminate-beta-galactosamide-alpha-2, 6-sialyltransferase 2; ST6Gal II; Sialyltransferase 2 |
| Clonality | Polyclonal |
|---|---|
| Isotype | Ig |
| Host Species | Rabbit |
| Tested Applications | WB |
| WB:1:100~500 |
|
| Species Reactivity | Human |
| Concentration | 1mg/ml |
| Gene Synonyms | KIAA1877 SIAT2 |
|---|---|
| Alternative Names | ST6GAL2 KIAA1877 SIAT2 Beta-galactoside alpha-2 6-sialyltransferase 2 CMP-N-acetylneuraminate-beta-galactosamide-alpha-2 6-sialyltransferase 2 ST6Gal II Sialyltransferase 2 |
| Molecular Weight(MW) | 60158 Da |
| Function | Transfers sialic acid from the donor of substrate CMP- sialic acid to galactose containing acceptor substrates. Has alpha-2,6-sialyltransferase activity toward oligosaccharides that have the Gal-beta-1,4-GlcNAc sequence at the non-reducing end of their carbohydrate groups, but it has weak or no activities toward glycoproteins and glycolipids |
| Tissue Specificity | Weakly expressed in some tissues, such as small intestine, colon and fetal brain |
| Cellular Localization | Golgi apparatus, Golgi stack membrane; Single-pass type II membrane protein (By similarity) |
| Entrez Gene | 84620 |
|---|---|
| Nucleotide Accession | NP_001135823.1 |
Application
ST6GAL2 Antibody (C-term) western blot analysis in HepG2 cell line lysates (35ug/lane).This demonstrates the ST6GAL2 antibody detected the ST6GAL2 protein (arrow).| Application Notes | WB:1:100~500 |
|---|
| Form | Liquid |
|---|---|
| Storage Instructions | For short-term storage, store at 4° C. For long-term storage, aliquot and store at -20ºC or below. Avoid multiple freeze-thaw cycles. |
| Storage Buffer | Purified polyclonal antibody supplied in PBS with 0.09% (W/V) sodium azide. This antibody is purified through a protein A column, followed by peptide affinity purification. |
